Sequence variability of the α-chemokine UL146 from clinical strains of human cytomegalovirus

Journal of Medical Virology

Volumn 74, Issue 4, 2004, Pages 573-579

  Hassan Walker, Aycan F ^a   Okwuadi, Sylvester ^a   Lee, Lydia ^a   Griffiths, Paul D ^a   Emery, Vincent C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ELRCXC; HCMV; Neutrophils; Pathogenesis

Indexed keywords

ALPHA CHEMOKINE;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC DIFFERENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CYTOMEGALOVIRUS; KIDNEY GRAFT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RECIPIENT; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS INFECTION; VIRUS STRAIN;

CHEMOKINES, CXC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; INFANT, NEWBORN; PHYLOGENY; TRANSPLANTATION; VARIATION (GENETICS); VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 7044220405     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20210     Document Type: Article

References (19)

1. Bale JF, Jr., Petheram SJ, Robertson M, Murph JR, Demmler G. 2001. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65:90-96.
2. Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF. 1999. Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162:6967-6970.
3. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78-83.
4. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA, III, Kouzarides T, Martignetti JA, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154:125-169.
5. Chou SW, Dennison KM. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163:1229-1234.
6. Clark-Lewis I, Schumacher C, Baggiolini M, Moser B. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 266:23128-23134.
7. Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. 1994. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 269:16075-16081.
8. Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ, McGeoch DJ, Hayward GS. 2003. The human cytomegalovirus genome revisited: Comparison with the chimpanzee cytomegalo-virus genome. J Gen Virol 84(Pt. 1):17-28.
9. Dolan A, Cunningham C, Ralph D, Hector RD, Hassan-Walker A, Lee L, Addison C, Dargan DJ, McGeoch D, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GWG, Davison A. 2004. Genetic content of wild type human cytomegalovirus. J Gen Virol 85:1301-1312.
10. Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA. 2002. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 186:114-117.
11. Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E, Benedict CA, Ware CF, Bremer JW. 1999. Human cytomegalovirus UL144 open reading frame: Sequence hypervariability in low-passage clinical isolates. J Virol 73:10040-10050.
12. McCormack GP, Clewley JP. 2002. The application of molecular phylogenetics to the analysis of viral genome diversity and evolution. Rev Med Virol 12:221-238.
13. Meyer-Konig U, Ebert K, Schrage B, Pollak S, Hufert FT. 1998a. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280-1281.
14. Meyer-Konig U, Haberland M, von Laer D, Haller O, Hufert FT. 1998b. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177:1162-1169.
15. Meyer-Konig U, Schrage B, Huzly D, Bongarts A, Hufert FT. 1998c. High variability of cytomegalovirus glycoprotein B gene and frequent multiple infections in HIV-infected patients with low CD4 T-cell count. Aids 12:2228-2230.
16. Meyer-Konig U, Vogelberg C, Bongarts A, Kampa D, Delbruck R, Wolff-Vorbeck G, Kirste G, Haberland M, Hufert FT, von Laer D. 1998d. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55:75-81.
17. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 96:9839-9844.
18. Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW. 2001. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol 11:191-200.
19. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.